Skip to content

DSD-Life: Clinical European study on the outcome of surgical and hormonal therapy and psychological intervention in disorders of sex development (DSD)

DSD-Life: Clinical European study on the outcome of surgical and hormonal therapy and psychological intervention in disorders of sex development (DSD) - DSD-Life

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON38614
Enrollment
205
Registered
2013-11-11
Start date
2013-11-01
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intersekse intersex

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
12 Years to 99 Years

Inclusion criteria

Inclusion criteria: Individuals with sex chromosome, XY DSD and XX DSD >= 16 years. Patients with psychiatric disorder will not be excluded. Their medical records are required Probands >= 16 -

Exclusion criteria

Exclusion criteria: Individuals without the mental capability to answer the questionnaires themselves Simultaneous participation in other studies investigating drugs or hormones.

Design outcomes

Primary

MeasureTime frame
Primary study parameter(s) Health status, health related quality of life, psychological and social well-being, gender dysphoria, experiences and satisfaction with sexuality. Primary endpoints: Identification of factors influencing psychosocial adaptation including, HRQoL and social - and psychological well-being, which can be improved in future clinical care.

Secondary

MeasureTime frame
Secondary study parameter(s) Sex assignment, genital surgery, hormone therapy, metabolism, fertility, psychosocial care, satisfaction with health care, psychosexual development, and hormone treatment. Secondary endpoints: Identification of factors affecting metabolism, fertility, surgical outcome and psychosexual development, which can be changed in future clinical care.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)